Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI

The medium‐dose etoposide (VP16) added on cyclophosphamide (CY)/total body irradiation (TBI) is one of the intensified myeloablative conditioning regimens used in allogenic hematopoietic stem cell transplantation (allo‐HSCT) for acute lymphoblastic leukemia (ALL). However, the patient subgroups who...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita‐Fujita, Mari, Arai, Yasuyuki, Kondo, Tadakazu, Harada, Kaito, Uchida, Naoyuki, Toya, Takashi, Ozawa, Yukiyasu, Fukuda, Takahiro, Ota, Shuichi, Onizuka, Makoto, Kanda, Yoshinobu, Maruyama, Yumiko, Takada, Satoru, Kawakita, Toshiro, Ara, Takahide, Ichinohe, Tatsuo, Kimura, Takafumi, Atsuta, Yoshiko, Kako, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084153/
https://www.ncbi.nlm.nih.gov/pubmed/35790020
http://dx.doi.org/10.1002/hon.3046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084153/
https://www.ncbi.nlm.nih.gov/pubmed/35790020
http://dx.doi.org/10.1002/hon.3046

Ejemplares similares